IL1B and metabolic dysfunction-associated steatotic liver disease: However, supplementation of β-sitosterol to rats fed on HFD significantly attenuated the increase in the inflammatory markers (IL-1β and iNOS), which is agree with the finding of Plat et al., (2014), suggesting an anti-inflammatory potential of β-sitosterol in NAFLD [26].